If approved, it will likely be the first oral treatment for covet 19. The trial was designed to be given to early in the course of infection. It's prescribed as four pills taken twice a day for five days.
Vox’s Umair Irfan explains how a new pill that might soon be authorized by the FDA could fill major gaps in treating Covid-19.
Today’s show was produced by Haleema Shah and Will Reid, edited by Matt Collette, engineered by Efim Shapiro, fact-checked by Laura Bullard and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices